Chemours Co CC

Healthcare SIC 2800 - Chemicals & Allied Products NAICS Manufacturing › Chemical Manufacturing derived NYSE

The Chemours Company (herein referred to as "we", "us", or "our") is a leading, global provider of performance chemicals that are key inputs in end-products and processes in a variety of industries. We deliver customized solutions with a wide range of industrial and specialty chemical products for markets, including refrigeration and air conditioning, paints and coatings, plastics, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our principal products include refrigerants, titanium dioxide ("TiO2") pigment and industrial fluoropolymer resins. We manage and report our operating results through three principal reportable segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. Our Thermal & Specialized Solutions segment is a leading, global provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. Our Titanium Technologies segment is a leading, global provider of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, and protection in a variety of applications. Our Advanced Performance Materials segment is a leading, global provider of high-end polymers and advanced materials that deliver unique attributes, including low friction coefficients, extreme temperature resistance, weather resistance, ultraviolet and chemical resistance, and electrical insulation.

Last close 12.81 2026-10-23
Market cap $1.93B 2026-06-30 share count
52-week range 10.44 - 28.67

Valuation FY2025 figures against the last close

P/S0.3x
P/E—
P/FCF37.8x
EV/EBITDA—
Dividend yield4.0%
Diluted EPS-2.57

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • North America
  • Asia Pacific
  • Europe, the Middle East, and Africa
  • Latin America
Revenue by geography, 4 categories over 3 years. The same figures are in the table below. FY2025 North America, FY2025: 2.7B (45.7%) 46% North America Asia Pacific, FY2025: 1.2B (21.4%) 21% Asia Pacific Europe, the Middle East, and Africa, FY2025: 1.2B (20.0%) 20% Latin America, FY2025: 748M (12.9%) 13% Latin America FY2024 North America, FY2024: 2.6B (44.8%) 45% Asia Pacific, FY2024: 1.4B (24.0%) 24% Europe, the Middle East, and Africa, FY2024: 1.1B (19.7%) 20% Latin America, FY2024: 669M (11.6%) 12% FY2023 North America, FY2023: 2.7B (45.2%) 45% Asia Pacific, FY2023: 1.5B (24.1%) 24% Europe, the Middle East, and Africa, FY2023: 1.2B (19.7%) 20% Latin America, FY2023: 674M (11.1%) 11%
Region FY2025FY2024FY2023
North America $2.65B $2.59B $2.75B
Asia Pacific $1.24B $1.39B $1.46B
Europe, the Middle East, and Africa $1.16B $1.14B $1.20B
Latin America $748.0M $669.0M $674.0M

As the company reported it, from the “Net Sales - Summary of Disaggregation of Net Sales by Geographical Region and Segment and Product Group (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $5.81B$5.78B$6.08B$6.83B$6.34B$4.97B$5.53B$6.64B$6.18B$5.40B
Cost of revenue $4.91B$4.64B$4.78B$5.21B$4.96B$3.90B$4.46B$4.67B$4.44B$4.30B
Gross profit $902.0M$1.14B$1.30B$1.62B$1.38B$1.07B$1.06B$1.97B$1.75B$1.10B
R&D $108.0M$109.0M$108.0M$118.0M$107.0M$93.0M$80.0M$82.0M$81.0M$81.0M
SG&A $799.0M$598.0M$1.29B$710.0M$592.0M$527.0M$548.0M$657.0M$626.0M$946.0M
Total operating expenses $966.0M$823.0M$1.55B$844.0M$705.0M$700.0M$715.0M$788.0M$764.0M$1.20B
Interest expense $269.0M$263.0M$208.0M$163.0M$185.0M$210.0M$208.0M$195.0M$214.0M$219.0M
Pre-tax income -$277.0M$106.0M-$318.0M$741.0M$676.0M$179.0M-$124.0M$1.16B$912.0M-$11.0M
Income tax $109.0M$37.0M$66.0M$163.0M$68.0M$40.0M$72.0M$159.0M$165.0M$18.0M
Net income -$386.0M$69.0M-$253.0M$578.0M$608.0M$219.0M-$52.0M$995.0M$746.0M$7.0M
EPS, basic -2.570.46-1.703.723.691.33-0.325.624.040.04
EPS, diluted -2.570.46-1.703.653.601.32-0.325.453.910.04
Shares, diluted (wtd. avg.) 150.2M150.2M148.9M158.3M168.7M166.3M164.8M182.6M191.0M183.4M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $670.0M$713.0M$1.20B$1.30B$1.55B$1.10B$943.0M$1.20B$1.56B$902.0M
Receivables $562.0M$619.0M$622.0M$509.0M$644.0M$449.0M$602.0M$790.0M$847.0M$742.0M
Inventory $1.57B$1.46B$1.35B$1.40B$1.10B$939.0M$1.08B$1.15B$935.0M$767.0M
Total current assets $3.00B$3.02B$3.84B$3.21B$3.35B$2.63B$2.78B$3.29B$3.49B$2.55B
Property, plant and equipment $3.13B$3.19B$3.21B$3.17B$3.15B$3.47B$3.56B$3.29B$3.01B$2.78B
Goodwill $46.0M$46.0M$102.0M$102.0M$102.0M$153.0M$153.0M—$153.0M$153.0M
Other intangibles $2.0M$3.0M$3.0M$13.0M$6.0M$14.0M$21.0M$28.0M$13.0M$17.0M
Total assets $7.46B$7.51B$8.24B$7.64B$7.55B$7.08B$7.26B$7.36B$7.29B$6.06B
Accounts payable $954.0M$1.16B$1.16B$1.23B$1.16B$844.0M$923.0M$1.14B$1.07B$884.0M
Short-term debt $42.0M$54.0M$51.0M$43.0M$25.0M$21.0M$134.0M$13.0M$15.0M$15.0M
Total current liabilities $1.83B$1.82B$2.49B$1.89B$1.86B$1.44B$1.54B$1.71B$1.65B$1.77B
Long-term debt $4.11B$4.06B$3.99B$3.59B$3.72B$4.00B$4.03B$3.96B$4.10B$3.53B
Total liabilities $7.23B$6.94B$7.52B$6.53B$6.47B$6.27B$6.56B$6.34B$6.43B$5.96B
Retained earnings $1.25B$1.69B$1.78B$2.17B$1.75B$1.30B$1.25B$1.47B$579.0M-$114.0M
Total equity $228.0M$571.0M$721.0M$1.11B$1.08B$815.0M$695.0M$1.02B$865.0M$104.0M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $264.0M-$633.0M$556.0M$755.0M$814.0M$807.0M$650.0M$1.14B$640.0M$594.0M
Depreciation and amortisation $340.0M$292.0M$309.0M$291.0M$317.0M$320.0M$311.0M$284.0M$273.0M$284.0M
Stock-based compensation $21.0M$15.0M$18.0M$27.0M$34.0M$16.0M$19.0M$24.0M$29.0M—
Capital expenditure $213.0M$360.0M$370.0M$307.0M$277.0M$267.0M$481.0M$498.0M$411.0M$338.0M
Investing cash flow -$206.0M-$353.0M-$229.0M-$284.0M$220.0M-$234.0M-$483.0M-$487.0M-$370.0M$357.0M
Financing cash flow -$126.0M-$36.0M$172.0M-$686.0M-$554.0M-$449.0M-$419.0M-$993.0M$352.0M-$396.0M
Dividends paid $78.0M$148.0M$149.0M$154.0M$164.0M$164.0M$164.0M$148.0M$22.0M$22.0M
Buybacks ——$69.0M$495.0M$173.0M$0$322.0M$644.0M$106.0M$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-065201.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -2B 0 2B 4B 6B 8B Revenue, FY2016: 5.4B Gross profit, FY2016: 1.1B Net income, FY2016: 7M Revenue, FY2017: 6.2B Gross profit, FY2017: 1.7B Net income, FY2017: 746M Revenue, FY2018: 6.6B Gross profit, FY2018: 2B Net income, FY2018: 995M Revenue, FY2019: 5.5B Gross profit, FY2019: 1.1B Net income, FY2019: -52M Revenue, FY2020: 5B Gross profit, FY2020: 1.1B Net income, FY2020: 219M Revenue, FY2021: 6.3B Gross profit, FY2021: 1.4B Net income, FY2021: 608M Revenue, FY2022: 6.8B Gross profit, FY2022: 1.6B Net income, FY2022: 578M Revenue, FY2023: 6.1B Gross profit, FY2023: 1.3B Net income, FY2023: -253M Revenue, FY2024: 5.8B Gross profit, FY2024: 1.1B Net income, FY2024: 69M Revenue, FY2025: 5.8B Gross profit, FY2025: 902M Net income, FY2025: -386M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $5.40B $6.18B $6.64B $5.53B $4.97B $6.34B $6.83B $6.08B $5.78B $5.81B
Gross profit $1.10B $1.75B $1.97B $1.06B $1.07B $1.38B $1.62B $1.30B $1.14B $902.0M
Net income $7.0M $746.0M $995.0M -$52.0M $219.0M $608.0M $578.0M -$253.0M $69.0M -$386.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Material agreement signed Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Other event Item 8.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2800

TickerCompanyMarket capP/ERevenue growth
SOLS Solstice Advanced Materials Inc. $9.44B 39.9x 3.1%
BCPC BALCHEM CORP $5.64B 37.3x 8.8%
PRM Perimeter Solutions, Inc. $4.55B — 16.4%
IOSP INNOSPEC INC. $2.43B 21.1x -3.7%
NGVT Ingevity Corp $2.39B — -2.7%
OLN OLIN Corp $1.78B — 3.7%
HUN Huntsman CORP $1.54B — -5.8%
ECVT Ecovyst Inc. $1.07B — 20.9%